Alcon
Alcon is a Switzerland-based medical device company that manufactures and supplies surgical and vision care products for the healthcare industry.
Business Model:
Revenue: $8.7B
Employees: 10,001-999,999
Rankings
Industries / Tags:
Detailed Alcon Information
Geographic Data
Address: Chemin de Blandonnet 8
City: Vernier
State: geneva
Zip: 1214
Country: CH
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
77,844Website Global Rank
1,381,043Website Monthly Traffic
Twitter Followers
Description
Alcon is a Switzerland-based medical device company that manufactures and supplies surgical and vision care products for the healthcare industry.
Contact Phone:
Contact Email:
Alcon went public on 3/21/2002 on the SIX Swiss Exchange
Listed Exchange:
SIX Swiss Exchange
IPO Date:
3/21/2002
IPO Valuation:
$10B
Ticker Symbol:
ALC
IPO Price:
$33/share
Amount Raised:
$2B
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2022 | Aurion Biotechnologies | Venture Round | 120M |
| 11/2012 | SensoMotoric Instruments (SMI) | Venture Round | - |
| 4/2022 | Aurion Biotechnologies | Venture Round | 0 |
| 11/2012 | SensoMotoric Instruments (SMI) | Venture Round | - |
| Announced Date | Name | Price |
|---|---|---|
| 11/2021 | Ivantis | |
| 3/2019 | PowerVision | |
| 12/2018 | Truevision | |
| 12/2018 | Tear Film Innovations | |
| 2/2016 | Transcend Medical | |
| 8/2014 | WaveTec Vision | |
| 7/2010 | LensX Lasers | |
| 9/2009 | ESBATech | |
| 9/2007 | WaveLight |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
